John Mendelsohn
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations, Cancer-related Molecular Pathways
Most-Cited Works
- → Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.(1996)1,401 cited
- → The EGF receptor family as targets for cancer therapy(2000)1,342 cited
- → Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer(2003)1,258 cited
- Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.(1998)
- → Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.(1983)795 cited
- Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.(1995)
- → Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin